An Innovative Epigenetic Merge in Treatment of AML Patients Correlates with Better "Molecular and Clinical” Outcomes

Clinical Outcomes for Patients with Acute Myeloid Leukemia Harboring IDH1 Mutation After Intensive Chemotherapy

Impact of Frailty Assessment on The Outcome of Acute Myeloid Leukemia in Elderly Patients

Epigenetics in Hematological Malignancies

CD96 as a Leukemic Stem Cell Marker in Acute Myeloid Leukemia Patients: Relation to Remission Induction Chemotherapy

NCCN and ESMO guidelines For the diagnosis and management of AML

Management of FLT-3 mutated AML

Emerging Role of Folate-Mediated One Carbon Metabolism in Leukemia: A Review

Cytogenetic studies of Acute Myeloid Leukemia

PROTEIN ARGININE METHYLTRANSFERASE 1 EXPRESSION LEVEL AND ITS PROGNOSTIC SIGNIFICANCE IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS